Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

alcon switzerland sa - natrii chloridum, hypromellosum - collirio - natrii chloridum 1 mg, hypromellosum 5 mg, natrii citras dihydricus, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 6.73 mg, benzalkonii chloridum 0.1 mg, aqua purificata, ad solutionem pro 1 ml. - lacrime artificiali - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - natrii fusidas - salve - natrii fusidas 20 mg, alcohol cetylicus 4 mg, adeps lanae 46 mg, paraffinum liquidum, vaselinum album, e 307, e 321 max. 9.2 µg, ad unguentum pro 1 g. - batteriche infezioni cutanee - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - natrii fusidas - compresse rivestite con film - natrii fusidas 250 mg corresp. natrium 10.7 mg, cellulosum microcristallinum, lactosum monohydricum 71.9 mg, crospovidonum, talcum, magnesii stearas, silica colloidalis anhydrica, e 307, Überzug: hypromellosum, e 171 pro compresso obducto. - malattie infettive - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - natrii valproas - soluzione - natrii valproas 300 mg, arom.: bergamottae aetheroleum, saccharinum natricum, e l'altro, conserv.: alcol benzylicus, excipiens ad una soluzione per 1 ml. - aed - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - natrii dihydrogenophosphas anhydricus, dinatrii phosphas - clistere - natrii dihydrogenophosphas anhydricus 139.1 mg, dinatrii phosphas 31.8 mg, e 211 1 mg, e 218 0.5 mg, natrii hydroxidum ad ph, aqua purificata ad solutionem pro 1 ml, pro vase 133 ml. - laxans - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

opella healthcare switzerland ag - natrii picosulfas monohydricus - gocce per uso orale, soluzione - natrii picosulfas monohydricus 7.5 mg corresp. natrii picosulfas 7.2 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 450 mg, natrii benzoas 2 mg, natrii citras dihydricus, acidum citricum monohydricum, aqua purificata ad solutionem pro 1 ml corresp. natrium 1.36 mg corresp. 15 guttae. - laxans - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - natrii valproas - sciroppo - natrii valproas 300 mg, arom.: saccharinum natricum, vanillinum e di altro colore.: e 124, conserv.: propylis parahydroxybenzoas, e 218, alcol benzylicus, excipiens ad una soluzione per 5 ml. - aed - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - natrii valproas - sirup - natrii valproas 50 mg, sono, saccharinum natricum, natrii cyclamas, conserv.: propylis parahydroxybenzoas, e 218, excipiens ad una soluzione per 1 ml. - antiepilepticum - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

gebro pharma ag - natrii chloridum, kalii chloridum, natrii citras dihydricus, glucosum - pulver zur herstellung einer lösung zum einnehmen im beutel - natrii chloridum 0.35 g, kalii chloridum 0.30 g, natrii citras dihydricus 0.59 g, glucosum 4.00 g, saccharinum natricum, aromatica golden syrup, aromatica tutti frutti cum alcohol benzylicus et propylenglycolum, silica colloidalis anhydrica, ad pulverem, pro charta corresp. natrium 276 mg, kalium 157 mg. - elettroliti per la reidratazione orale - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

omnivision ag - natrii chloridum - collirio - natrii chloridum 50 mg, trometamolum, natrii acetas trihydricus, acidum aceticum 30 per centum, hypromellosum, benzalkonii chloridum 0.1 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - trattamento del corneaoedems - synthetika